Answers are grounded in this paper and cite their sources.
Retrospective analysis evaluates glycemic control indicators using a decision support system in diabetes management, highlighting its potential utility.
Background: We evaluated whether the frequency of algorithm-generated coaching events, a decision support system (DSS) integrated with a smart insulin pen (SIP), differed according to glycemic outcomes, thereby establishing the algorithmic foundation. Methods: This retrospective analysis evaluated continuous glucose monitoring (CGM) and SIP data from a 12-week randomized controlled trial (NCT06406439) involving individuals with diabetes managed with multiple daily injections (MDI). A total of 338 biweekly CGM profiles from 58 participants were analyzed. For each 14-day period, the coaching event frequency was calculated across 9 predefined coaching categories. Results: Frequencies of hyperglycemia-related coaching (time in range [TIR]: 18.8 vs 34.8; time above range [TAR > 180 mg/dL]: 18.3 vs 33.8) and missed bolus events (TIR: 7.6 vs 11.2; TAR: 7.0 vs 11.1) were significantly higher in profiles not meeting hyperglycemia-related CGM targets (all P < .001). Both coaching categories demonstrated good discrimination for TIR and TAR target achievement (all area under the curve [AUC] > 0.7). Frequency of missed basal detection also showed significant associations with achievement of TIR and TAR targets (all P < .05). The hypoglycemia coaching group effectively discriminated the absence of nocturnal time below range <54 mg/dL (AUC = 0.740). Basal insulin titration coaching frequencies were associated with nocturnal mean glucose changes (all P < .005). Real-time insulin and correction factor reduction recommendations were independently associated with deterioration in TIR and TAR metrics (all P < .05). Conclusions: The frequency of algorithm-based coaching events served as a robust indicator of glycemic control. These findings validate Stage 5 SIP-integrated DSS and suggest its potential utility in identifying unresolved glycemic issues in individuals treated with MDI.
No takes yet. Share an insight, caveat, or question.
Yoo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: